Sarfez is a mission-based pharmaceutical research and development company focused on providing better treatment options for cardio-renal diseases. By focusing on improving existing drugs, Sarfez Pharmaceuticals shortens the timeline of product development. These efficiencies reduce the risk to our enterprise and keep our costs reasonable. In turn, we are committed to passing along these cost savings to the patient in a fully transparent manner.
We achieve this by:
Analyzing the experiences of patients
Forging alliances with specialized and best-in-class companies
Bringing extensive academic knowledge and expertise from our team
Receiving our funding from non-diluted sources of government grants, allowing us to stay true to our purpose of improving existing medications at a reasonable cost
Additional Info
ACC.20/WCC Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies